In fiscal 2026, which ended Mar 28, 2026, Transcat, Inc. generated $34.9 million of cash from operations, down 10.6% from the year before. It spent $15.3 million on capital expenditures. That left free cash flow of $19.6 million. The company returned $469,000 in share buybacks to shareholders.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2027
Sep 26, 2026
|
FY 2026
Mar 28, 2026
|
FY 2025
Mar 29, 2025
|
FY 2024
Mar 30, 2024
|
FY 2023
Mar 25, 2023
|
FY 2022
Mar 26, 2022
|
FY 2021
Mar 27, 2021
|
FY 2019
Mar 28, 2020
|
FY 2018
Mar 30, 2019
|
FY 2017
Mar 31, 2018
|
FY 2014
Mar 28, 2015
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||
| Depreciation and amortization |
28
+25.9%
|
26
+41.0%
|
19
+37.1%
|
14
+23.6%
|
11
+14.5%
|
10
+26.2%
|
8
|
7
+4.7%
|
6
+6.2%
|
6
-3.1%
|
3
+4.9%
|
| Stock-based compensation |
9
+90.9%
|
8
+132.4%
|
3
-28.0%
|
5
+33.6%
|
3
+45.0%
|
2
+53.9%
|
2
|
1
-33.4%
|
1
-6.0%
|
1
+211.5%
|
1
-3.8%
|
| Operating cash flow |
37
-6.1%
|
35
-10.6%
|
39
+19.5%
|
33
+92.4%
|
17
-3.8%
|
18
-25.5%
|
24
|
12
-8.0%
|
13
+27.2%
|
10
|
4
-41.7%
|
| Investing | |||||||||||
| Capital expenditures |
14
-1.8%
|
15
+15.9%
|
13
-0.6%
|
13
+41.1%
|
9
-7.3%
|
10
+53.4%
|
7
|
7
-6.0%
|
7
+19.0%
|
6
+12.0%
|
4
+78.5%
|
| Investing cash flow |
-40
+76.0%
|
-98
-16.5%
|
-84
-101.6%
|
-42
-125.1%
|
-19
+53.5%
|
-40
-292.6%
|
-10
|
-20
-85.6%
|
-11
-85.7%
|
-6
|
-11
-526.6%
|
| Financing | |||||||||||
| Debt issued |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
2
-65.0%
|
7
-28.6%
|
—
|
| Debt repaid |
—
|
—
|
2
+4.0%
|
2
+6.0%
|
2
+0.3%
|
2
+6.7%
|
2
|
2
-9.0%
|
2
+20.9%
|
2
+31.8%
|
—
|
| Stock buybacks |
—
|
0
-86.8%
|
4
-27.3%
|
5
+997.5%
|
0
-93.3%
|
7
+119.2%
|
3
|
3
+1846.2%
|
0
-59.7%
|
0
+267.3%
|
0
-98.9%
|
| Financing cash flow |
3
-97.2%
|
67
+147.6%
|
27
-2.0%
|
27
+3027.7%
|
1
-96.3%
|
24
+287.2%
|
-13
|
8
+582.8%
|
-2
+57.1%
|
-4
|
5
+175.7%
|
| Change in cash | |||||||||||
| Effect of exchange rate |
—
|
—
|
—
|
—
|
—
|
-1
|
—
|
—
|
—
|
—
|
—
|
| Net change in cash |
1
+103.6%
|
3
+118.9%
|
-18
-200.1%
|
18
+13318.5%
|
0
-83.9%
|
1
+1270.5%
|
0
|
-0
|
—
|
—
|
—
|
| Free cash flow |
23
-8.6%
|
20
-24.2%
|
26
+33.4%
|
19
+156.5%
|
8
+1.0%
|
7
-56.1%
|
17
|
5
-10.4%
|
6
+39.4%
|
4
|
1
-83.4%
|
| Per share | |||||||||||
| Free cash flow per share |
2.44
-9.4%
|
2.08
-25.2%
|
2.79
+20.4%
|
2.32
+134.8%
|
0.99
+0.2%
|
0.98
-56.4%
|
2.26
|
0.67
-10.1%
|
0.74
+35.4%
|
0.55
|
0.13
-82.7%
|
| Shareholder returns | |||||||||||
| Returned to shareholders |
—
|
0
|
4
|
5
|
0
|
7
|
3
|
3
|
0
|
0
|
0
|
| Share of free cash flow |
—
|
2.40%
|
13.82%
|
25.37%
|
5.93%
|
89.51%
|
17.91%
|
56.64%
|
2.61%
|
9.02%
|
7.56%
|
| Ratios | |||||||||||
| Free cash flow margin |
6.32%
|
5.89%
|
9.26%
|
7.45%
|
3.27%
|
3.64%
|
9.82%
|
2.88%
|
3.46%
|
2.57%
|
0.76%
|
| Capital expenditures to revenue |
3.95%
|
4.61%
|
4.74%
|
5.12%
|
4.08%
|
4.95%
|
3.82%
|
3.80%
|
4.35%
|
3.79%
|
2.83%
|
| Stock-based compensation to revenue |
2.42%
|
2.27%
|
1.17%
|
1.74%
|
1.46%
|
1.14%
|
0.87%
|
0.51%
|
0.82%
|
0.91%
|
0.41%
|
| Cash conversion |
8.13x
|
6.48x
|
2.69x
|
2.39x
|
1.59x
|
1.55x
|
3.03x
|
1.43x
|
1.76x
|
1.67x
|
1.10x
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Instruments For Meas & Testing of Electricity & Elec Signals (SIC 3825)
- Listed as
- TRNS (Nasdaq)
- Fiscal year ends
- March 27
- Incorporated in
- OH
- Headquarters
- Rochester, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 99302
- Former names
- TRANSMATION INC (until Aug 14, 2002)
Other Instruments For Meas & Testing of Electricity & Elec Signals companies
- Teradyne, Inc TER
- Veralto Corp VLTO
- Itron, Inc. ITRI
- Cohu Inc COHU
- Aehr Test Systems AEHR
- Allient Inc ALNT
- Frequency Electronics Inc FEIM
- Intest Corp INTT
All 11 Instruments For Meas & Testing of Electricity & Elec Signals companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.